All In MedTech

FDA Clearance Tracker · P000058-S020

INFUSE BONE GRAFT/LT-CAGE TAPERED FUSION DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 21, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 21, 2007

Approved

Time to decision

420 days

Received Oct 27, 2006. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P000058-S020
Device name
INFUSE BONE GRAFT/LT-CAGE TAPERED FUSION DEVICE
Applicant location
Memphis, TN
Received
Oct 27, 2006
Decided
Dec 21, 2007
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P000058

Device type

Device class
Class III

Every decision under product code NEK

FDA's approval statement

As written in FDA's record.

APPROVAL FOR CHANGES TO THE PACKAGE INSERT AND KIT BOX TEXT BASED ON REPORTS ASSOCIATED WITH SEVERAL TYPES OF AES. THESE AES WERE THE PRESENCE OF FLUID-FILLED CYSTS OR RADIOGRAPHIC EVIDENCE OF PERI-IMPLANT TRANSIENT BONE RESORPTION. IT?S BELIEVED THAT OVERPACKING OF THE ACS COMPONENT WITHIN A CONFINED SPACE AND/OR HYPERCONCENTRATING THE RHBMP-2 SOLUTION WERE RESPONSIBLE FOR THE AES.

Source documents

Other decisions for Medtronic Sofamor Danek USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.